...Ltd. $69.1 Series B Andera Partners, Biodiscovery, Quan Capital, Quan Ventures, Sofinnova Partners, IP Group, EMBL Ventures...

...virus program, for which Boehringer was responsible for R&D costs. Boehringer Ingelheim Venture Fund and EMBL Ventures...

...virus program, for which Boehringer was responsible for R&D costs. Boehringer Ingelheim Venture Fund and EMBL Ventures...

...GV and Alexandria Venture Investments. Existing investors OrbiMed, Polaris Venture Partners, SV Health Investors, NeoMed, EMBL Ventures...

...Venture Investments, as well as existing investors OrbiMed, Polaris Venture Partners, SV Health Investors, NeoMed, EMBL Ventures...

...the first close of a series A round co-led by Boehringer Ingelheim Venture Fund and EMBL Ventures. BC...

...EUR22 million ($24.8 million) Investors: Delos Capital; Forbion Capital Partners; Edmond de Rothschild Investment Partners; EMBL Ventures...

...by new investor Delos Capital. Existing investors Forbion Capital Partners, Edmond de Rothschild Investment Partners, EMBL Ventures...

...million ($15.8 million) in the first close of a series A round from Epidarex Capital, EMBL Ventures...
...partners: None Number of employees: 4 Funds raised: €14 million ($15.8 million) Investors: Epidarex Capital, EMBL Ventures...

...product after Phase I testing. Epidarex Capital led the series A and was joined by EMBL Ventures...